News

Weight-loss company Noom pivots to smaller doses of compounded Wegovy
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk’s Wegovy as the U.S.
Novo Nordisk Places Bet on CEO Shake-Up to Reclaim Edge in Weight Loss Drug Race
As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...
People With PCOS Are Taking GLP-1s for Their Symptoms. Here’s What to Know
While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...
STAT7h
Pharmalittle: We’re reading about FDA eyeing PDUFA changes, compounded weight loss drugs, and more
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
Le Lézard8h
Scripta Insights Launches GLP-1 Navigator as Americans Scramble for Weight Loss Drug Answers
Scripta Insights, the doctor-driven, AI-powered pharmacy navigation company that guides self-insured employers, health plans and their members to prescription savings, announces today its GLP-1 ...
Compounded versions of weight loss shots in short supply
Compounding pharmacies are supposed to stop producing the compounded versions of the popular weight loss medications now that ...
Explore more
Nearly a third of Americans aren't filling their prescriptions because of high costs
GoodRx ran a 12-month survey to better understand the dynamics that shape prescription medication fills and consumer behavior, and found affordability, access issues, and drug shortages prevent many ...